Literature DB >> 23489257

Patients with severe aortic stenosis and reduced ejection fraction: earlier recovery of left ventricular systolic function after transcatheter aortic valve implantation compared with surgical valve replacement.

Fabrice Bauer1, Véronique Coutant, Mathieu Bernard, Dimitri Stepowski, Christophe Tron, Alain Cribier, Jean-Paul Bessou, Hélène Eltchaninoff.   

Abstract

BACKGROUND: Only 50% of patients with aortic stenosis (AS) and low ejection fraction (EF) improve their contractility after surgical aortic valve replacement (AVR). Long-term prognosis of these patients is strongly correlated to EF recovery after the surgery. The aim of this study was to compare the postoperative left ventricular function recovery in patients with severe AS and reduced EF after AVR and transcatheter aortic valve implantation (TAVI). METHODS AND
RESULTS: Twenty-one patients undergoing AVR for severe AS (<1 cm²) and reduced EF (<45%) were echocardiographically compared with 31 patients treated with TAVI by conventional and two-dimensional (2D) strain method. TAVI patients were older (83 ± 6 vs. 74 ± 13 years, P < 0.001), had more comorbidities (Euroscore 26 ± 15% vs. 16 ± 12%, P < 0.001) and no differences in ischemic heart disease (16.1% vs. 9.5%, P = 0.39). EF was similar in both groups at baseline. Aortic valve area significantly increased (P = 0.01) while pressure gradient decreased (P = 0.009) after both procedures but TAVI was associated with a better EF recovery compared with AVR at day 7. Regional function assessed by radial 2D strain increased in TAVI group but was transiently deteriorated in AVR patients (P < 0.05). Longitudinal as well as circumferential 2D strain progressively increased at follow-up in both groups (P < 0.05). EF was similar in both groups at 3-month follow-up.
CONCLUSION: In patients with severe AS and reduced EF, TAVI is associated with faster and better recovery of LV function compared with AVR.
© 2013, Wiley Periodicals, Inc.

Entities:  

Keywords:  aortic stenosis; aortic valve surgery; left ventricular function; prognosis; transcatheter valve implantation

Mesh:

Year:  2013        PMID: 23489257     DOI: 10.1111/echo.12171

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

Review 1.  Efficacy of transcatheter aortic valve implantation in patients with aortic stenosis and reduced LVEF. A systematic review.

Authors:  X Luo; Z Zhao; H Chai; C Zhang; Y Liao; Q Li; Y Peng; W Liu; X Ren; Q Meng; C Chen; M Chen; Y Feng; D Huang
Journal:  Herz       Date:  2015-02-26       Impact factor: 1.443

Review 2.  Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.

Authors:  Ares Pasipoularides
Journal:  J Cardiovasc Transl Res       Date:  2016-05-16       Impact factor: 4.132

3.  Impact of selected comorbidities on the presentation and management of aortic stenosis.

Authors:  Tanja K Rudolph; David Messika-Zeitoun; Norbert Frey; Jeetendra Thambyrajah; Antonio Serra; Eberhard Schulz; Jiri Maly; Marco Aiello; Guy Lloyd; Alessandro Santo Bortone; Alberto Clerici; Georg Delle-Karth; Johannes Rieber; Ciro Indolfi; Massimo Mancone; Loic Belle; Alexander Lauten; Martin Arnold; Berto J Bouma; Matthias Lutz; Cornelia Deutsch; Jana Kurucova; Martin Thoenes; Peter Bramlage; Richard P Steeds
Journal:  Open Heart       Date:  2020-07

4.  Mortality after transcatheter versus surgical aortic valve replacement: an updated meta-analysis of randomised trials.

Authors:  H Takagi; Y Hari; K Nakashima; T Kuno; T Ando
Journal:  Neth Heart J       Date:  2020-06       Impact factor: 2.380

5.  Early Recovery of Left Ventricular Systolic Function after Transcatheter Aortic Valve Implantation.

Authors:  Wanda Deste; Simona Gulino; Paolo Zappulla; Federica Iacono; Rita Sicuso; Antonino Indelicato; P Ines Monte; Giulia Rapisarda; Danilo Trovato; Arianna Cirasa; Carmelo Sgroi; Marco Barbanti; Corrado Tamburino
Journal:  J Cardiovasc Echogr       Date:  2018 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.